Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 29 results found. Search for [ dexamethasone used for ]

Results 1 to 21 of 29
BusinessToday.In
January 27, 2021
Coronvirus treatment: Plitidepsin, according to the researchers, should be considered for clinical trials based on its in vivo study results. Plitidepsin aka Aplidin is owned by Spanish pharmaceutical company Pharma Mar


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


Reuters
November 16, 2020
The U.S. drugmaker plans to enrol up to 30,000 participants for the study and run it in parallel with a one-dose trial with as many as 60,000 volunteers that began in September


PB Jayakumar
November 3, 2020
Zydus today said it has filed an Investigational New Drug (IND) application for 'ZYIL1', an oral drug candidate, that has found to be effective in pre-clinic studies to control inflammation in COVID-19 related diseases


PB Jayakumar
September 11, 2020
\"It (candidate drug PNB-001) has shown remarkable results in lung inflammation and ARDS (Acute Respiratory Distress Syndrome)\", says PN Balaram, CEO of PNB Vesper


PB Jayakumar
September 3, 2020
WHO's recommendation is based on three new studies, plus four other earlier trials, all involving a drug from the family of corticosteroids


PB Jayakumar
August 13, 2020
Remdesivir price: Zydus is the fifth Indian company to launch the drug for coronavirus treatment after Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences. Priced at Rs 2,800 for a 100 mg lyophilized injection, its brand 'Remdac' will be the most economical


Reuters
July 22, 2020
In results announced last month, a trial by researchers in the United Kingdom showed dexamethasone as the first drug to save lives of COVID-19 patients in what scientists said was a major breakthrough in the coronavirus pandemic


Associated Press
July 20, 2020
For months before studies like these, learning what helps or harms has been undermined by \"desperation science\" as doctors and patients tried therapies on their own or through a host of studies not strong enough to give clear answers


Reuters
July 4, 2020
A week ago, European Medicines Agency gave its go-ahead for remdesivir to be used in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support


BusinessToday.In
New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough


E Kumar Sharma
New Delhi, June 27, 2020
\"Remdesavir seems to be useful for those who are coping with the beginning part of the disease and dexamethasone is useful for those who have to deal with the disease in its later phase within the body\"


Rupa Burman Roy
June 27, 2020
As per researchers led by a team from the University of Oxford, Dexamethasone has proven to reduced chances of dying from COVID-19 patients on ventilation by as much as 35% and patients on oxygen by 20%


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus vaccine update: Moderna has signed a deal with Catalent for large-scale manufacturing of its vaccine candidate. Catalent will provide vial filling and packaging capacity as well as additional workforce required for 24X7 manufacturing operations.


PB Jayakumar
June 24, 2020
Remdesivir, allowed for emergency use in COVID-19 patients from May 1, is currently given as an injection and can be used only in hospitals


BusinessToday.In
New Delhi, June 18, 2020
Coronavirus vaccine update: Germany's CureVac AG has received approval from the government to conduct human trials. The coronavirus vaccine candidate would first be tested 168 health people according to the government


Associated Press
June 18, 2020
On Tuesday, when the British researchers announced their findings, the department of health said the dexamethasone had been approved to treat all hospitalized COVID-19 patients, effectively immediately


PTI
New Delhi, June 18, 2020
According to scientists, the drug has been proven to reduce the risk of death significantly in COVID-19 patients on ventilation by as much as 35 per cent and patients on oxygen by 20 per cent


BusinessToday.In
New Delhi, June 17, 2020
Scores of domestic flights in and out of Beijing were cancelled on Wednesday as officials ramped up attempts to contain a coronavirus outbreak in the Chinese capital; Dexamethasone, a time-tested steroid used to treat inflammation, can reduce death up to one-third in hospitalised patients with severe respiratory complications of COVID-19, an important large clinical trial by the University of Oxford has said; The US State Department issued a statement on Wednesday regarding the India-China standoff at the Galwan Valley region of Eastern Ladakh. Watch the video for more.Also Read: India-China face-off: Chinese media downplays Galwan Valley border clashes


PTI
June 17, 2020
The Centre had earlier opposed the plea and said these are extraordinary circumstances and the website has been developed for easy accessibility of medicines to COVID-19 patients


PAGES 1 OF 2  12